Clinical and research issues in neonatal anemia and thrombocytopenia

Current Opinion in Pediatrics

Volumn 24, Issue 1, 2012, Pages 16-22

  Sallmon, Hannes ^a   Sola Visner, Martha ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

anemia of prematurity; erythropoietin; neonatal thrombocytopenia; thrombopoietin; transfusions

Indexed keywords

ERYTHROPOIETIN; HEMOPOIETIC GROWTH FACTOR; RECOMBINANT HEMOPOIETIC GROWTH FACTOR; THROMBOPOIETIN; UNCLASSIFIED DRUG;

DRUG APPROVAL; DRUG RESEARCH; ERYTHROCYTE TRANSFUSION; HUMAN; NECROTIZING ENTEROCOLITIS; NEONATAL THROMBOCYTOPENIA; NEWBORN ANEMIA; NONHUMAN; PRIORITY JOURNAL; REVIEW; THROMBOCYTE TRANSFUSION;

ADULT; ANEMIA, NEONATAL; ERYTHROCYTE TRANSFUSION; FOLLOW-UP STUDIES; GUIDELINES AS TOPIC; HUMANS; INFANT; INFANT, NEWBORN; PLATELET COUNT; PLATELET TRANSFUSION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; THROMBOCYTOPENIA; THROMBOPOIETIN;

EID: 84856111106     PISSN: 10408703     EISSN: 1531698X     Source Type: Journal    
DOI: 10.1097/MOP.0b013e32834ee5cc     Document Type: Review

References (44)

1. Bell EF, Strauss RG, Widness JA, et al. Randomized trial of liberal versus restrictive guidelines for red blood cell transfusion in preterm infants. Pediatrics 2005; 115:1685-1691. (Pubitemid 43843180)
2. Kirpalani H, Whyte RK, Andersen C, et al. The Premature Infants in Need of Transfusion (PINT) study: a randomized, controlled trial of a restrictive (low) versus liberal (high) transfusion threshold for extremely low birth weight infants. J Pediatr 2006; 149:301-307.
3. Chen HL, Tseng HI, Lu CC, et al. Effect of blood transfusions on the outcome of very low body weight preterm infants under two different transfusion criteria. Pediatr Neonatol 2009; 50:110-116.
4. Whyte RK, Kirpalani H, Asztalos EV, et al. Neurodevelopmental outcome of extremely low birth weight infants randomly assigned to restrictive or liberal hemoglobin thresholds for blood transfusion. Pediatrics 2009; 123:207-213.
5. McCoy TE, Conrad AL, Richman LC, et al. Neurocognitive profiles of preterm infants randomly assigned to lower or higher hematocrit thresholds for transfusion. Child Neuropsychol 2011; 17:347-367. In this study, investigators evaluated neurocognitive and academic functioning in 56 school-age children who were originally enrolled in the Iowa RBC transfusion trial. This study found that infants randomized as neonates to the liberal transfusion arm performed significantly worse in tests of associative verbal fluency, visual memory, and reading compared with infants randomized to the restrictive arm.
6. Nopoulos PC, Conrad AL, Bell EF, et al. Long-term outcome of brain structure in premature infants: effects of liberal vs restricted red blood cell transfusions. Arch Pediatr Adolesc Med 2011; 165:443-450. This study evaluated brain volume measurements in MRI scans performed at 12 years of age in former preterm infants randomized to the liberal vs. restrictive RBC transfusion arm in the Iowa trial. Brain volumes were significantly smaller in infants in the liberal group, particularly in girls, compared with those in the restrictive group.
7. Mally P, Golombek SG, Mishra R, et al. Association of necrotizing enterocolitis with elective packed red blood cell transfusions in stable, growing, premature neonates. Am J Perinatol 2006; 23:451-458. (Pubitemid 46535109)
8. Christensen RD, Lambert DK, Henry E, et al. Is 'transfusion-associated necrotizing enterocolitis' an authentic pathogenic entity? Transfusion 2010; 50:1106-1112. This is one of the largest studies describing the development of necrotizing enterocolitis within 48 h of a RBC transfusion.
9. Josephson CD, Wesolowski A, Bao G, et al. Do red cell transfusions increase the risk of necrotizing enterocolitis in premature infants? J Pediatr 2010; 157:972-978. e1-3.
10. Blau J, Calo JM, Dozor D, et al. Transfusion-related acute gut injury: necrotizing enterocolitis in very low birth weight neonates after packed red blood cell transfusion. J Pediatr 2011; 158:403-409. This study proposed the hypothesis that transfusion-associated NEC could have similar pathogenesis to transfusion-associated lung injury, and coined the now popular term 'Transfusion-Associated Gut Injury' (TRAGI).
11. Paul DA, Mackley A, Novitsky A, et al. Increased odds of necrotizing enterocolitis after transfusion of red blood cells in premature infants. Pediatrics 2011; 127:635-641. This is one of the largest studies describing the development of necrotizing enterocolitis within 48 h of a RBC transfusion.
12. Singh R, Visintainer PF, Frantz ID 3rd, et al. Association of necrotizing enterocolitis with anemia and packed red blood cell transfusions in preterm infants. J Perinatol 2011; 31:176-182.
13. El-Dib M, Narang S, Lee E, et al. Red blood cell transfusion, feeding and necrotizing enterocolitis in preterm infants. J Perinatol 2011; 31:183-187.
14. Gladwin MT, Kim-Shapiro DB. Storage lesion in banked blood due to hemolysis-dependent disruption of nitric oxide homeostasis. Curr Opin Hematol 2009; 16:515-523.
15. Krimmel GA, Baker R, Yanowitz TD. Blood transfusion alters the superior mesenteric artery blood flow velocity response to feeding in premature infants. Am J Perinatol 2009; 26:99-105.
16. Dani C, Pratesi S, Fontanelli G, et al. Blood transfusions increase cerebral, splanchnic, and renal oxygenation in anemic preterm infants. Transfusion 2010; 50:1220-1226.
17. Christensen RD, Henry E, Wiedmeier SE, et al. Thrombocytopenia among extremely low birth weight neonates: data from a multihospital healthcare system. J Perinatol 2006; 26:348-353. (Pubitemid 43811510)
18. Josephson CD, Su LL, Christensen RD, et al. Platelet transfusion practices among neonatologists in the United States and Canada: results of a survey. Pediatrics 2009; 123:278-285.
19. Cremer M, Sola-Visner M, Roll S, et al. Platelet transfusions in neonates: practices in the United States vary significantly from those in Austria, Germany, and Switzerland. Transfusion 2011. [Epub ahead of print] This study is of importance because it exposed marked differences in platelet transfusion practices between US and European neonatologists, and suggested that a significantly higher number of infants receive platelet transfusions in the United States compared with some European countries, only on the basis of practice differences.
20. Andrew M, Vegh P, Caco C, et al. A randomized, controlled trial of platelet transfusions in thrombocytopenic premature infants. J Pediatr 1993; 123:285-291. (Pubitemid 23221114)
21. Stanworth SJ, Clarke P, Watts T, et al. Prospective, observational study of outcomes in neonates with severe thrombocytopenia. Pediatrics 2009; 124:e826-e834.
22. Baer VL, Lambert DK, Henry E, et al. Severe Thrombocytopenia in the NICU. Pediatrics 2009; 124:e1095-e1100.
23. von Lindern JS, van den Bruele T, Lopriore E, et al. Thrombocytopenia in neonates and the risk of intraventricular hemorrhage: a retrospective cohort study. BMC Pediatrics 2011; 11:16. This study found that neonates with thrombocytopenia, in general, have a significantly higher mortality and risk of IVH compared with nonthrombocytopenic neonates. However, there was no association between the severity of the thrombocytopenia and these risks.
24. Ohlsson A, Aher SM. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2006; 3:CD004863.
25. Strauss RG. Anaemia of prematurity: pathophysiology and treatment. Blood Rev 2011; 24:221-225. This review provides a contemporary overview of the pathophysiology and management of neonatal anemia, including transfusion therapy and the use of Epo.
26. Aher S, Ohlsson A. Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2006; 3:CD004868.
27. Suk KK, Dunbar JA, Liu A, et al. Human recombinant erythropoietin and the incidence of retinopathy of prematurity: a multiple regression model. J AAPOS 2008; 12:233-238. (Pubitemid 351853461)
28. Juul SE, McPherson RJ, Bammler TK, et al. Recombinant erythropoietin is neuroprotective in a novel mouse oxidative injury model. Dev Neurosci 2008; 30:231-242. (Pubitemid 351653366)
29. Juul SE, McPherson RJ, Bauer LA, et al. A phase I/II trial of high-dose erythropoietin in extremely low birth weight infants: pharmacokinetics and safety. Pediatrics 2008; 122:383-391.
30. Fauchere JC, Dame C, Vonthein R, et al. An approach to using recombinant erythropoietin for neuroprotection in very preterm infants. Pediatrics 2008; 122:375-382.
31. Zhu C, Kang W, Xu F, et al. Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy. Pediatrics 2009; 124:e218-e226.
32. Basser RL, O'Flaherty E, Green M, et al. Development of pancytopenia with neutralizing antibodies to thrombopoietin after multicycle chemotherapy supported by megakaryocyte growth and development factor. Blood 2002; 99:2599-2602. (Pubitemid 34525451)
33. Li J, Yang C, Xia Y, et al. Thrombocytopenia caused by the development of antibodies to thrombopoietin. Blood 2001; 98:3241-3248.
34. Bussel JB, Cheng G, Saleh MN, et al. Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura. N Engl J Med 2007; 357:2237-2247. (Pubitemid 350190754)
35. Bussel JB, Kuter DJ, George JN, et al. AMG 531, a thrombopoiesis- stimulating protein, for chronic ITP. N Engl J Med 2006; 355:1672-1681. (Pubitemid 44583957)
36. Bussel JB, Buchanan GR, Nugent DJ, et al. A randomized, double-blind study of romiplostim to determine its safety and efficacy in children with immune thrombocytopenia. Blood 2011; 118:28-36. This is the first study on the use of thrombopoietic growth factors in pediatric patients. It showed that the use of romiplostim in children aged 1-18 years with chronic ITP is effective and well tolerated. However, no patients younger than a year were enrolled.
37. Sallmon H, Gutti RK, Ferrer-Marin F, et al. Increasing platelets without transfusion: is it time to introduce novel thrombopoietic agents in neonatal care? J Perinatol 2010; 30:765-769. This review discusses in detail the potential, limitations, and concerns associated with the use of thrombopoietic growth factors in neonates.
38. Cremer M, Paetzold J, Schmalisch G, et al. Immature platelet fraction as novel laboratory parameter predicting the course of neonatal thrombocytopenia. Br J Haematol 2009; 144:619-621.
39. Pecci A, Gresele P, Klersy C, et al. Eltrombopag for the treatment of the inherited thrombocytopenia deriving from MYH9 mutations. Blood 2011; 116:5832-5837.
40. Liu ZJ, Italiano J Jr, Ferrer-Marin F, et al. Developmental differences in megakaryocytopoiesis are associated with up-regulated TPO signaling through mTOR and elevated GATA-1 levels in neonatal megakaryocytes. Blood 2011; 117:4106-4117. This study demonstrated that neonatal megakaryocytes exhibit a different pattern of maturation compared with adultmegakaryocytes, characterized by rapid proliferation and full terminal maturation without polyploidization. These findings challenged the widely accepted notion that neonatal megakaryocytes are 'immature'.
41. Pastos KM, Slayton WB, Rimsza LM, et al. Differential effects of recombinant thrombopoietin and bone marrow stromal-conditioned media on neonatal versus adult megakaryocytes. Blood 2006; 108:3360-3362.
42. Sola MC, Du Y, Hutson AD, et al. Dose-response relationship of megakaryocyte progenitors from the bone marrow of thrombocytopenic and nonthrombocytopenic neonates to recombinant thrombopoietin. Br J Haematol 2000; 110:449-453. (Pubitemid 30646876)
43. Ivanova A, Wuerfel J, Zhang J, et al. Expression pattern of the thrombopoietin receptor (Mpl) in the murine central nervous system. BMC Dev Biol 2010; 10:77. This study demonstrated that the Tpo receptor (c-mpl) is present in the brain, and that its distribution changes throughout development.
44. Ehrenreich H, Hasselblatt M, Knerlich F, et al. A he-matopoietic growth factor, thrombopoietin, has a proapoptotic role in the brain. Proc Natl Acad Sci U S A 2005; 102:862-867 (Pubitemid 40282756)